-
US FDA releases guidance to detect and prevent nitrosamines in drugs
expresspharma
September 03, 2020
The US Food and Drug Administration (US FDA) has published guidance ‘Control of Nitrosamine Impurities in Human Drugs’ for immediate implementation.
-
NPPA fixes retail prices of 30 formulations, rejects four applications
expresspharma
August 24, 2020
The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 30 formulations under the provision of the Drugs (Prices Control) Order (DPCO) 2013.
-
Researchers find three drugs on market that induce side effects in C. elegans
europeanpharmaceuticalreview
August 19, 2020
A study has found that three prescription drugs on the market cause unexpected side effects in the C. elegans worm, meaning they could have unknown effects in humans.
-
Commonly used treatments for chronic pain do not work, says NICE
europeanpharmaceuticalreview
August 06, 2020
NICE has said commonly used treatments for chronic primary pain such as paracetamol have little or no evidence that they work and should not be prescribed for the condition.
-
X-ray structure analysis gives detailed insights into bacterial molecular factory
expresspharma
July 08, 2020
A team of the Technical University of Munich (TUM) and the Goethe University Frankfurt has now succeeded in investigating the basic mechanisms of molecular factories.
-
COVID-19 mouse model will speed search for drugs, vaccines
worldpharmanews
June 11, 2020
The global effort to quickly develop drugs and vaccines for COVID-19 has been hampered by limited numbers of laboratory mice that are susceptible to infection with SARS-CoV-2, the virus that causes COVID-19.
-
Top 50 Drugs by Sales to Sample Hospitals in China in 2019
PharmaSources/Caicai
May 26, 2020
According to the PDB data, the data of the top 50 drugs by sales to sample hospitals in China in 2019 have been fresh out recently, with the total sales of the top 50 reaching RMB76.414 billion and the minimum requirement for listing being RMB910 million.
-
Industry lauds move to allow import of drugs with 60 per cent residual shelf life
expresspharma
April 26, 2020
Revised guidelines will ease the movement of goods and enable timely access to medicines, benefitting both pharma companies and patients.
-
CDSCO allows import of COVID-19 drugs with less than 60 per cent shelf life
expresspharma
April 20, 2020
The import of such drugs may be permitted after taking an undertaking from the importers by the port officers of CDSCO that the drug will be utilised or consumed before the expiry date and ...
-
CDSCO instructs pharma industry associations to share drug availability stock report
expresspharma
April 20, 2020
DGHS shares a list of 55 drugs for ICU management COVID-19 patients and 96 drugs of general category containing essential drugs.